Schedule 13G ownership disclosure

Vanda Pharmaceuticals Inc

Security class unavailable · CUSIP: 921659108

Event date: 2019-02-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,345,571
Percent of class
8.2900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-19-000011
Form type
SC 13G/A
Filer
Palo Alto Investors LP
CIK
CIK 1306923
Filed
Feb 19, 2019
Reporting period
Feb 07, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub